Concepedia

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors

Amikar Sehdev, Theodore Karrison, Yuanyuan Zha, Linda Janisch, Michelle Turcich, Ezra E.W. Cohen, Michael L. Maitland, Blasé N. Polite, Thomas F. Gajewski, Ravi Salgia,

Cancer Chemotherapy and Pharmacology · 2018 · 17 citations · 16 references

DOIFull text

Open access

Concepts

References

16

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

C. J. Currie, C Poole, E.A.M. Gale · Diabetologia · 2009 · 1.1K citations · Full text

, , +13

New Users of Metformin Are at Low Risk of Incident Cancer

Gillian Libby, Louise A. Donnelly, Peter T. Donnan et al. · Diabetes Care · 2009 · 986 citations · Full text

, , +13

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

Sao Jiralerspong, Shana L. Palla, Sharon H. Giordano et al. · Journal of Clinical Oncology · 2009 · 877 citations · Full text

, , +9

Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

Josep Tabernero, Federico Rojo, Emiliano Calvo et al. · Journal of Clinical Oncology · 2008 · 532 citations

, , +17